Renoprotective effects of valsartan and enalapril in STZ-induced diabetes in rats

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.

Roberto Zatz, B R Dunn, Timothy W. Meyer et al. · Journal of Clinical Investigation · 1986 · 1.2K citations · Full text

Hypertension, Pharmacological Amelioration, Glomerulonephritis +21

Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

Shoji Kagami, Wayne A. Border, Diane E. Miller et al. · Journal of Clinical Investigation · 1994 · 1.1K citations · Full text

Glomerular Disease, Immunology, Pathology +23

Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice

Kumar Sharma, Yulin Jin, Jia Guo et al. · Diabetes · 1996 · 661 citations

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass.

Richard Lafayette, Gert Mayer, S K Park et al. · Journal of Clinical Investigation · 1992 · 347 citations · Full text

Glomerular Disease, Hypertension, Reduced Renal Mass +22

Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides.

Duncan J. Campbell, Athena Kladis, Ann-Maree Duncan · Hypertension · 1994 · 315 citations

Hypertension, Cardiovascular Pharmacology, Plasma Angiotensin Ii +17